NDAORALTABLET
Approved
Jan 2014
Lifecycle
Peak
Competitive Pressure
30/100
Data completeness
2/8 — Basic
Drug data last refreshed 4h ago · AI intelligence enriched 6d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ALEVE PM is a fixed-dose combination oral tablet containing naproxen sodium (a nonsteroidal anti-inflammatory drug) and diphenhydramine hydrochloride (a first-generation antihistamine with sedating properties). It is indicated for the temporary relief of minor aches and pains due to headache, muscular aches, backache, minor arthritis pain, menstrual cramps, and the common cold, while the diphenhydramine component aids sleep. The mechanism combines NSAID anti-inflammatory and analgesic action with anticholinergic sedation to address pain and sleep disruption simultaneously.
Peak
Product is at peak lifecycle stage with moderate competitive pressure (30/100), suggesting established market presence but with ongoing brand defense requirements for the commercial team.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on ALEVE PM offers exposure to OTC brand management, retail channel dynamics, and consumer-focused commercial strategy within a stable, peak-lifecycle portfolio. Career progression typically involves brand defense, channel optimization, and line extension development rather than clinical trial management or breakthrough innovation.
Brand ManagerField Sales Representative
Worked on ALEVE PM at Bayer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.